83 FR 24317 - Advisory Commission on Childhood Vaccines

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration

Federal Register Volume 83, Issue 102 (May 25, 2018)

In accordance with the Federal Advisory Committee Act, this notice announces that the Advisory Commission on Childhood Vaccines (ACCV) will hold a public meeting. This meeting will be open to the public.

[Federal Register Volume 83, Number 102 (Friday, May 25, 2018)]
[Notices]
[Pages 24317-24318]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-11298]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Service Administration


Advisory Commission on Childhood Vaccines

AGENCY: Health Resources and Service Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice of Advisory Committee meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Advisory Commission on Childhood Vaccines 
(ACCV) will hold a public meeting. This meeting will be open to the 
public.

DATES: Friday, June 15, 2018, from 10:00 a.m. to 2:00 p.m. ET.

ADDRESSES: The meeting is a teleconference and webinar. The conference 
call-in number is 1-800-988-0218; passcode: 9302948. The webinar link 
is https://hrsa.connectsolutions.com/accv/. Participants should call 
and connect 15 minutes prior to the meeting in order for logistics to 
be set up. If you have never attended an Adobe Connect meeting, please 
test your connection using the following URL: https://hrsa.connectsolutions.com/common/help/en/support/meeting_test.htm and 
get a quick overview by following URL: http://www.adobe.com/go/connectpro_overview.

FOR FURTHER INFORMATION CONTACT: Annie Herzog, Principal Staff Liaison, 
Division of Injury Compensation Programs (DICP), Healthcare Systems 
Bureau (HSB), HRSA, 5600 Fishers Lane, Room 08N146B, Rockville, 
Maryland 20857; phone: (301) 443-6593; or email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Background: The ACCV advises the Secretary on the implementation of 
the Vaccine Injury Compensation Program (VICP). Other activities of the 
ACCV include: Recommending changes to the Vaccine Injury table, at its 
own initiative or as the result of the filing of a petition; advising 
the Secretary on implementing section 2127 of the Public Health Service 
Act (PHS Act) regarding

[[Page 24318]]

the need for childhood vaccination products that result in fewer or no 
significant adverse reactions; surveying federal, state, and local 
programs and activities related to gathering information on injuries 
associated with the administration of childhood vaccines, including the 
adverse reaction reporting requirements of section 2125 (b) of the PHS 
Act; advising the Secretary on the methods of obtaining, compiling, 
publishing, and using credible data related to the frequency and 
severity of adverse reactions associated with childhood vaccines; 
consulting on the development or revision of Vaccine Information 
Statements; and recommending to the Director of the National Vaccine 
Program research related to vaccine injuries which should be conducted 
to carry out the VICP.
    Agenda: During the June 15, 2018, meeting, agenda items may include 
updates from DICP, Department of Justice (DOJ), National Vaccine 
Program Office (NVPO), Immunization Safety Office (Centers for Disease 
Control and Prevention), National Institute of Allergy and Infectious 
Diseases (National Institutes of Health) and Center for Biologics, 
Evaluation and Research (Food and Drug Administration). Information 
about the ACCV, a roster of members, the meeting agenda, as well as 
past meeting summaries, is located on the ACCV website: http://www.hrsa.gov/advisorycommittees/childhoodvaccines/index.html. Agenda 
items are subject to change as priorities dictate.
    Public Participation: Members of the public will have the 
opportunity to provide comments. Oral comments will be honored in the 
order they are requested and may be limited as time allows. Requests to 
make oral comments or provide written comments to the ACCV should be 
sent to Annie Herzog by June 5, 2018. Individuals who plan to 
participate and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should notify Annie 
Herzog, using the address and phone number above at least 10 days prior 
to the meeting.

Amy P. McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2018-11298 Filed 5-24-18; 8:45 am]
 BILLING CODE 4165-15-P